Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Robert Bowser
AddedMar 31, 2024
UpdatedMay 31, 2026
Robert Bowser

Robert Bowser

Founder, nVector

Crunchbase

Robert Bowser's Career

nVector
nVector

Phoenix, AZ, US

Founder
Knopp Biosciences
Knopp Biosciences

Pittsburgh, PA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Robert Bowser's Career

nVector
nVector
Seed$125k82022Phoenix, AZ, US
Founder

Similar to nVector

NeuroVision ImagingNeuroVision ImagingSacramento, CA, USDiagnostic Testsest. 2010NeuroVision ImagingSacramento, CA, US · est. 2010

NeuroVision develops diagnostic tests and biomarkers for Alzheimer's, using novel retinal imaging tech and data analysis.

Series B · $21.2M12
AivoCodeAivoCodeSan Diego, CA, USNeurotechnologyest. 2016AivoCodeSan Diego, CA, US · est. 2016

AivoCode: Pioneering neurotech for improved treatment of neurological diseases.

Seed · $5.6M8
Neuro42Neuro42Oakland, CA, USMedical Devicesest. 2020Neuro42Oakland, CA, US · est. 2020

neuro42: Innovating advanced MRI tech for diagnosing and treating neurological conditions.

Series B · $12.8M26
NanoDxNanoDxSouthborough, MA, USMedical Devicesest. 2010NanoDxSouthborough, MA, US · est. 2010

NanoDx develops rapid point-of-care medical devices for diagnosing and managing traumatic brain injuries.

Series C · $37.9M38
Knopp Biosciences
Knopp Biosciences
Series C$164M102004Pittsburgh, PA, US
Co-Founder

Leadership at Knopp Biosciences

Shane KovacsShane KovacsBoard Member
Gregory HebrankGregory HebrankCo-Founder
Dave AdairDave AdairBoard Member
Dr. Michael E. BozikDr. Michael E. BozikCEO

Similar to Knopp Biosciences

KBP BiosciencesKBP BiosciencesPrinceton, NJ, USDrug Developmentest. 2007KBP BiosciencesPrinceton, NJ, US · est. 2007

KBP pioneers in drug development, focusing on lung, heart, kidney diseases, and immunology, leveraging unique insights for innovative therapies.

Series A · $76M51
Caden BiosciencesCaden BiosciencesMadison, WI, USPharmaceuticalsest. 2000Caden BiosciencesMadison, WI, US · est. 2000

Discovering & developing pharmaceuticals for nervous system disorders.

Series A · $5.8M5
Bioscience Pharma PartnersBioscience Pharma PartnersScottsdale, AZ, USDrug Developmentest. 2014Bioscience Pharma PartnersScottsdale, AZ, US · est. 2014

Bioscience Pharma Partners: Pioneering drug R&D, focusing on anti-neuroinflammatory treatments.

Seed · $2.5M30
Harmony BiosciencesHarmony BiosciencesPlymouth Meeting, PA, USPharmaceuticalsest. 2017Harmony BiosciencesPlymouth Meeting, PA, US · est. 2017

Harmony Biosciences: Innovating therapies for rare neurological disorders in the U.S.

Public · $1.2B200

Robert Bowser's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · KakaoJB LEEJB LEECo-Founder · Kakao

People Similar to Robert Bowser

Bill HarringtonBill HarringtonBoard Member · Hyalex OrthopaedicsDerek SmallDerek SmallFounder · Luson BioventuresAlan KaganovAlan KaganovBoard Member · AtriCureKeith L. BlackKeith L. BlackCo-Founder · NeuroVision ImagingDavid LangerDavid LangerCo-Founder · Playback HealthJohn BowersJohn BowersCo-Founder · Nexus Photonics